PKM and hepatocellular carcinoma: Unlike inhibitors, PKM2 activators display antitumor effects by enhancing pyruvate kinase activity, resulting in complete glycolysis and decreased anabolism, thereby inhibiting the growth of solid tumors including HCC [102,103].